News Conference News SCAI 2017 Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year By L.A. McKeown May 18, 2017
News Conference News EuroPCR 2017 BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI By Michael O'Riordan May 18, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years By Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters By Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year By Shelley Wood May 17, 2017
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone By Yael L. Maxwell May 17, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan By Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial By Shelley Wood May 16, 2017
News Conference News EuroPCR 2017 iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows By Caitlin E. Cox May 16, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit By Michael O'Riordan May 16, 2017